Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport
- PMID: 3643022
- PMCID: PMC1147155
- DOI: 10.1042/bj2380443
Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport
Abstract
Dinitrophenyl S-glutathione is accumulated by inside-out vesicles made from human erythrocytes in a process totally dependent on ATP and Mg2+. The vesicles were shown to accumulate dinitrophenyl S-glutathione against a concentration gradient. The vesicles were able to concentrate this glutathione derivative even in the absence of membrane potential. This indicated that the ATP-dependent uptake of dinitrophenyl S-glutathione by inside-out vesicles represented an active transport process. Neither extravesicular EGTA nor intravesicular ouabain inhibited the transport process, indicating that neither the Ca2+-ATPase nor the Na+, K+-ATPase were involved. These results indicated that dinitrophenyl S-glutathione uptake by inside-out vesicles probably represented primary active transport. The uptake of dinitrophenyl S-glutathione was a linear function of time (up to 5 h) and vesicle protein. The rate of uptake was optimal between pH 7.0 and 8.0 and at 37 degrees C. The Km values determined for dinitrophenyl S-glutathione and ATP were 0.29 mM and 1 mM, respectively. The transport process was completely inhibited by vanadate and by p-hydroxymercuribenzene sulphonate and inhibited to a lesser extent by N-ethylmaleimide. GTP could efficiently substitute for ATP as an energy source for the transport process, but CTP and UTP were comparatively much less effective.
Similar articles
-
Evidence for different transport systems for oxidized glutathione and S-dinitrophenyl glutathione in human erythrocytes.Biochem Biophys Res Commun. 1986 Sep 14;139(2):538-44. doi: 10.1016/s0006-291x(86)80024-9. Biochem Biophys Res Commun. 1986. PMID: 3767975
-
ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles.J Biol Chem. 1989 Oct 15;264(29):17343-8. J Biol Chem. 1989. PMID: 2793858
-
ATP-dependent transport of glutathione-N-ethylmaleimide conjugate across erythrocyte membrane.Biochem Med Metab Biol. 1994 Dec;53(2):105-14. doi: 10.1006/bmmb.1994.1065. Biochem Med Metab Biol. 1994. PMID: 7710766
-
Glutathione S-conjugate transport using inside-out vesicles from human erythrocytes.Eur J Biochem. 1982 Jul;125(3):551-4. doi: 10.1111/j.1432-1033.1982.tb06717.x. Eur J Biochem. 1982. PMID: 7117253
-
Red blood cell calcium pump and its inhibition by vanadate and lanthanum.J Cardiovasc Pharmacol. 1986;8 Suppl 8:S33-7. doi: 10.1097/00005344-198600088-00007. J Cardiovasc Pharmacol. 1986. PMID: 2433522 Review. No abstract available.
Cited by
-
ATP dependent primary active transport of xenobiotic-glutathione conjugates by human erythrocyte membrane.Mol Cell Biochem. 1989 Nov 23-Dec 19;91(1-2):131-6. doi: 10.1007/BF00228088. Mol Cell Biochem. 1989. PMID: 2533663
-
Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells).Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):759-64. doi: 10.1042/bj2900759. Biochem J. 1993. PMID: 8096130 Free PMC article.
-
RLIP76: a versatile transporter and an emerging target for cancer therapy.Biochem Pharmacol. 2010 Jun 15;79(12):1699-705. doi: 10.1016/j.bcp.2010.01.016. Epub 2010 Jan 25. Biochem Pharmacol. 2010. PMID: 20097178 Free PMC article. Review.
-
Organic anions exhibit distinct inhibition patterns on the low-Km and high-Km transport of S-(2,4-dinitrophenyl)glutathione through the human erythrocyte membrane.Biochem J. 1993 May 15;292 ( Pt 1)(Pt 1):171-4. doi: 10.1042/bj2920171. Biochem J. 1993. PMID: 8503844 Free PMC article.
-
Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.Lung Cancer (Auckl). 2013;2013(4):61-69. doi: 10.2147/LCTT.S53672. Lung Cancer (Auckl). 2013. PMID: 25419163 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous